These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 18637038
1. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review. Grosso S, Cordelli DM, Coppola G, Franzoni E, Verrotti A, Berardi R, Balestri P. Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038 [Abstract] [Full Text] [Related]
2. Efficacy and safety of felbamate in children with refractory epilepsy. Heyman E, Levin N, Lahat E, Epstein O, Gandelman-Marton R. Eur J Paediatr Neurol; 2014 Nov; 18(6):658-62. PubMed ID: 24906615 [Abstract] [Full Text] [Related]
3. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD, Singh K, Friedman D, Devinsky O, Kothare SV. Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692 [Abstract] [Full Text] [Related]
4. Efficacy of felbamate in therapy for partial epilepsy in children. Carmant L, Holmes GL, Sawyer S, Rifai N, Anderson J, Mikati MA. J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763 [Abstract] [Full Text] [Related]
5. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Palmer KJ, McTavish D. Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493 [Abstract] [Full Text] [Related]
6. [Therapeutic drug monitoring of felbamate]. Tribut O, Bentué-Ferrer D, Verdier MC, le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Therapie; 2010 Jun; 65(1):35-8. PubMed ID: 20205993 [Abstract] [Full Text] [Related]
7. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Zupanc ML, Roell Werner R, Schwabe MS, O'Connor SE, Marcuccilli CJ, Hecox KE, Chico MS, Eggener KA. Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190 [Abstract] [Full Text] [Related]
8. Felbamate in an adult population with severe refractory epilepsy. Kearney H, Delanty N. Ir Med J; 2009 Jun; 102(10):326-8. PubMed ID: 20108801 [Abstract] [Full Text] [Related]
9. Felbamate as an add-on therapy for refractory epilepsy. Shi LL, Dong J, Ni H, Geng J, Wu T. Cochrane Database Syst Rev; 2011 Jan 19; (1):CD008295. PubMed ID: 21249704 [Abstract] [Full Text] [Related]
10. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Perry MS, Benatar M. Epilepsia; 2007 Jun 19; 48(6):1123-7. PubMed ID: 17430408 [Abstract] [Full Text] [Related]
11. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Felbamate Study Group in Lennox-Gastaut Syndrome. N Engl J Med; 1993 Jan 07; 328(1):29-33. PubMed ID: 8347179 [Abstract] [Full Text] [Related]
12. Felbamate: consensus of current clinical experience. Pellock JM, Faught E, Leppik IE, Shinnar S, Zupanc ML. Epilepsy Res; 2006 Oct 07; 71(2-3):89-101. PubMed ID: 16889941 [Abstract] [Full Text] [Related]
13. Felbamate. Pellock JM. Epilepsia; 1999 Oct 07; 40 Suppl 5():S57-62. PubMed ID: 10530695 [Abstract] [Full Text] [Related]
14. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group. Avanzini G, Canger R, Dalla Bernardina B, Vigevano F. Epilepsy Res; 1996 Nov 07; 25(3):249-55. PubMed ID: 8956923 [Abstract] [Full Text] [Related]
15. Felbamate levels in patients with epilepsy. Harden CL, Trifiletti R, Kutt H. Epilepsia; 1996 Mar 07; 37(3):280-3. PubMed ID: 8598188 [Abstract] [Full Text] [Related]
16. Increased seizure frequency associated with felbamate withdrawal in adults. Welty TE, Privitera M, Shukla R. Arch Neurol; 1998 May 07; 55(5):641-5. PubMed ID: 9605720 [Abstract] [Full Text] [Related]
18. [Felbamate: a long-term study in subjects with refractory epilepsy]. De Romanis F, Sopranzi N. Clin Ter; 1997 Mar 07; 148(3):83-7. PubMed ID: 9377844 [Abstract] [Full Text] [Related]